We determined that the human papillomavirus type 18 (HPV18) regulatory region contains one functional GRE sequence that interacts with the glucocorticoid receptor. This sequence conferred a moderate hormonal activation to the HPV18 P 105 promoter. Two modulators of glucocorticoid hormone activity, AP1 and hbrm, both involved in P 105 transcription, were found not to interfere with this hormonal activation. ᭧
The human papillomavirus type 18 (HPV18) has been has been shown to contain responsive elements for numerous cellular factors including AP1 (9) , NF1/CTF, and found to be associated with the etiology of cervical carci-KRF/Oct (10) . Additional binding sites for transcription nomas, along with few other viral types forming the sofactors are present more proximal to the promoter initiacalled ''high risk'' group. Members of this group have tion site, including Sp1 (11, 12) , YY1 (13), AP1, and an been shown to express two transforming proteins, E6
Oct related site (14) . In addition this region also contains which interacts with p53 and induces its degradation and binding sites for the viral E2 transcriptional regulator as E7 which interacts with the product of the cellular Rb well as the origin of viral DNA replication. The E2 binding tumor suppressor gene (1) (2) (3) . Transcription of these two site most proximal to the promoter TATA box has been oncogenes is apparently tightly regulated by a complex shown to mediate repression of the E6/E7 promoter activarray of cellular and viral proteins. This regulation may ity by E2 (12, 15) , while the three E2 binding sites are be modified by integration of the viral genome, an event crucial for viral DNA replication (16, 17) . It should be frequently occurring during carcinogenic progression.
noted that this region of approximately 200 nt is devoid The pattern of integration has been shown to be conof any intrinsic transcriptional activity in the absence of served, keeping intact a genomic fragment containing its transcriptional enhancer (14) . Within this proximal rethe whole regulatory region and the E6 and E7 genes, gion, we found by computer search two putative GRE with a specific interruption in the downstream E1 and/or elements, one at position 7756 containing 7 of 12 con-E2 ORFs (4, 5) . In the free or integrated genomic form, served residues with regard to the consensus GRE setranscription of the viral oncogenes is under the control quence (CCAACA N3 TGTCTA) and a second one at of numerous cellular factors, among which, are steroid position 7839 containing 9 of 12 conserved residues hormone receptors. Epidemiological studies have raised (AGCACA N3 TATACT). The existence of two potential the possibility that the hormonal status of the infected sites might be correlated with the bimodal glucocorticoid person, such as pregnancy, may influence the developactivation of the LCR of HPV18 linked to the lacZ gene ment of HPV-associated lesions (6) .
in transgenic mice (18) . Analysis by mutagenesis of PCRSequences resembling glucocorticoid hormone recepamplified DNA containing the two putative GRE sites tor response elements (GREs) have been identified in indicated that only the GRE element at position 7839 is the regulatory regions of HPVs associated with genital hormone responsive (data not shown). Contrary to nulesions (7) . The HPV16 genome has been shown to conmerous hormone-responsive promoters where synertain such an element in its transcriptional enhancer (8) .
gistic activation between at least two hormone-responIn the HPV18 genome, the cell-type-specific enhancer sive elements occurs (19) , the HPV18 P 105 promoter thus appears to respond only to a single GRE element. This
Activation of GRE tk CAT by the glucocorticoid hormone receptor. tk-CAT expression plasmids (0.5 mg) were cotransfected with 50 ng of either the mutant glucocorticoid receptor (GRm) (black bars) or the wild-type GR (gray bars) expression plasmids in C33 cells by the standard calcium phosphate coprecipitation method (29) . The constitutive GR and its mutated version were expressed under a CMV promoter, as previously described (30) . CAT assays were done 40 hr posttransfection, results given are the mean of at least three experiments that were standardized with the use of a cotransfected B-galactosidase reporter plasmid in each plate, and error bars are the calculated standard deviations. (B) Binding of purified GR to wild-type and mutated GRE sequences. Purified glucocorticoid hormone receptor obtained from bacterial extracts was used for binding assays with end-labeled probes by Klenow filling. Probes contain either wild-type (GRE18), AGCACA N3 TATACT, or mutated, AGCAAA N3 TATACT, sequences from HPV18 or a consensus GRE sequence (GREc), AGAACA N3 TGTTCT. Binding assays were performed under standard conditions, in the absence of nonspecific competitor DNA. Briefly, proteins were incubated with the labeled probes in the presence of 12 mM HEPES (pH 7.9), 0.5 mM EDTA, 4 mM MgCl 2 , 60 mM KCl, and 20 mM spermidine. Competitions were done on a GREc-labeled probe with excess unlabeled oligonucleotides containing the HPV18 or consensus GRE sequences using increasing molar excess as indicated at the top of each lane.
We further examined whether this GRE sequence N 3 TATACT) or a consensus GRE sequence (AGAACA N 3 TGTTCT) and cloned either one or two copies of them could cooperate to increase the hormonal response when multimerized. We synthesized oligonucleotides in front of the minimal thimidine kinase (tk) promoter.
As shown in Fig. 1A , both sequences mediated efficient containing either this HPV18 GRE sequence (AGCACA glucocorticoid receptor (GR)-dependent activation of the tk promoter. In addition, both sequences increased the hormonal response when duplicated, although the HPV18 sequence was less efficient than the consensus GRE.
To further compare the activity of the HPV18 GRE with the consensus sequence, both oligonucleotides were used in gel shift assays with a purified GR protein produced in bacteria. Both sequences were bound by the purified GR; however, the consensus sequence bound with a higher efficiency, as shown in direct binding assays in Fig. 1B (compare lanes b, GR binding to the HPV18 GRE, with lanes d and g, GR binding to the consensus GRE). In competition experiments, with excess unlabeled oligonucleotides, both the GREc and the GRE18 sequences competed for the binding of GR to the consensus sequence (Fig. 1B, lanes c to i) . In contrast, a mutated oligonucleotide containing a base change in one of the conserved nucleotides of the HPV18 GRE element (AGCAAA N 3 TATACT) was neither bound by the purified GR (Fig. 1B, lane a) nor did it compete for GR binding (data not shown).
We next examined whether the P 105 /CAT plasmid, containing the entire regulatory region cloned upstream of the CAT gene (20), could be activated by cotransfection with a constitutively expressed wild-type or mutated GR noted that control experiments (not shown) with highly GR (gray bars) or mutated GR (white bars) expression plasmids by the standard calcium phosphate cotransfection method (29) . The wild-type responsive regulatory regions such as the MMTV proplasmid P 105 -wt has been described (9), and P 105 -GREm contains a moter showed a very high hormonal activation (30-to single-base-pair mutation in the GRE, as described in the text and in 50-fold) in similar conditions. It therefore indicated the the legend to Fig. 1 . CAT assays were done 40 hr after transfection.
presence of high concentrations of endogenous GR upon
The values given represent the mean of at least three independent transfection of the expression plasmid. In order to contransfection experiments. (B) HeLa cells were transfected either with the wild-type P 105 promoter in front of CAT (l) or with the one containing firm that the site that we identified by in vitro binding the single GRE mutation (᭺). Cells were treated for 24 hr with different was indeed responsible for this activation of transcription molar concentrations of dexamethasone, as indicated. Cell extracts in the context of the whole HPV18 long control region, and CAT assays were done 40 hr after transfection. Each point is the we introduced the point mutation within the GRE seaverage of three independent transfection experiments.
quence that was shown to abolish GR binding in vitro (Fig. 1B, lane a) . We found that this mutation decreased the promoter basal level and when cotransfected with endogenous receptors. A transfected HPV18 P 105 wildtype/CAT plasmid was activated 2-to 3-fold in different the constitutive GR, its transcription was further repressed ( Fig. 2A) . This result unambiguously indicated experiments by dexamethasone treatment, but not the one containing a mutated GRE sequence (Fig. 2B) . In that the activation observed with the wild-type sequence was due to the presence of an intact GRE sequence. The contrast, we could not detect hormonal activation of the P 105 promoter in the mammary tumor cell line MCF7 unusual effect of the point mutation raises the possibility that another cellular factor might bind to this site and which expresses a high level of endogenous receptors, but does not support basal P 105 transcription (data not cooperate with the glucocorticoid receptor. However, gel shift assays with nuclear extracts failed, until now, to shown). Our experiments indicated that a single point mutation detect such a protein (results not shown). When the levels of both mutated and wild-type P 105 transcription were in the GRE sequence is sufficient to abolish the glucocorticoid responsiveness of the HPV18 P 105 promoter. In compared in the presence of cotransfected GR, the wildtype sequence was 10-fold more active than the mutated addition, we have also shown that the single or multimerized GRE sequence of HPV18 can efficiently confer gluone (compare the two gray columns in Fig. 2A ). Direct activation of HPV18 transcription by glucocorticoids cocorticoid responsiveness to a minimal promoter. The single point mutation that we have introduced in this GRE could also be observed in HeLa cells, which contain
Transcriptional activation by the glucocorticoid hormone receptor of HPV18 P 105 promoters mutated in AP1 binding sites. The HPV18 P 105 / CAT plasmids, either wt or mutated in either one or both AP1 binding sites (9) , are schematically represented at the bottom of the figure (crossed triangles indicate mutated AP1 binding sites). Two micrograms of each plasmid was cotransfected with 50 ng of GR (gray bars) or GR-mutated (white bars) expression plasmids in C33 cells, as described in Fig. 2. (A to C) led to a decrease in the basal activity of the P 105 quence can repress the AP1 activity. The concomitant promoter. This is in contrast with a double point mutation presence of TREs and GRE in a regulatory region can (AA to GG) introduced in the same element by Butz and constitute ''composite elements'' as in the proliferin gene, Hoppe-Seyler (1993) that led to increased basal activity for instance (23). Regulation of these composite elements of this promoter (11) . Opposite effects of different GRE led to either activation or repression. Our results indicate mutants could be due to different sequence changes that that the TRE and GRE of HPV18 do not constitute comwould affect other regulatory elements located in close posite elements since both sequences are located far proximity, such as a YY1 element located just few bases from each other and seem to be regulated independently. from the GRE. Another possibility is that endogenous Another explanation for the weak hormonal activation hormonal receptors could interact with this sequence in of the HPV18 transcription could be that full activation the absence of transfected GR and modulate the basal requires another cellular factor(s). The cellular hbrm pro-P 105 activity.
tein, a constituent of a complex that modulates chromatin The weak hormonal activation of P 105 (two-to threefold) could result from a putative negative interference of the receptor with AP1, an essential element of the promoter (9), since it is well documented that a complex crosstalk exists between glucocorticoid hormone receptor and the AP1 complex (21, 22) . In several cases they antagonize each other while in others they cooperate in transcriptional activation. Since the HPV18 regulatory region contains two AP1-responsive sites and a GRE, we investigated whether these elements interfere or synergize with each other. In agreement with previous results, single or double AP1 mutations in the P 105 promoter decreased its activity; however, all mutants were still activated roughly twofold by glucocorticoid receptor, as observed for the wild-type promoter (Fig. 3) . These Fig. 2A) , still raising the possibility 2. Values plotted on the curves are the result of a typical transfection experiment.
that excess GR in the absence of its target DNA se-chardt for the gift of purified bacterial GR and for the gift of the CMV structure, could represent such a candidate since it has hbrm expression plasmid, R. Ovseiovich for participating in the generabeen shown to potentiate GR activation (24). We theretion of the GRE mutant, F. Arnos for technical help, and Christian Defore investigated the putative involvement of hbrm in the saintes for critical reading of the manuscript. This work was supported GR-mediated activation of HPV18 transcription. Cotransin part by grants from CONACYT (1705M9209) and the Miguel Alemá n fection of a cytomegalovirus promoter (CMV) hbrm exFoundation, the ARC, and the LNFCC.
pression plasmid with the P 105 CAT plasmid in the C33 cell line (which does not express endogenous hbrm) pro
